Navigation Links
Breakthrough in radiotherapy promises targeted cancer treatment
Date:5/19/2009

Current radiation therapy treatment damages a patient's healthy tissue as well as eradicating the tumour it is intended to destroy, making the treatment especially invasive and often causing nasty side effects.

A new development in radiotherapy will enable a far more precise and accurate treatment for cancerous tumours by using real-time images to guide the radiation beam.

Real-time image-guided radiotherapy, combining radiation treatment with non-invasive MR imaging, would be far less harmful for patients as it would leave less healthy tissue damaged and give radiation oncologists the possibility of instantly modifying the treatment dose as tumours change in size and shift.

Published in issue 12 of IOP Publishing's Physics in Medicine & Biology the findings of a research group from the University Medical Centre Utrecht in the Netherlands are set to "open the door to start testing MRI-guided radiation therapy in the clinic".

The team of researchers has successfully proven that simultaneous radiation treatment and diagnostic-quality MRI is feasible. By actively shielding the radiation beam from the MRI scanner's magnet and redesigning the treatment room set-up, which has until now been difficult to put into practice, the researchers have managed to produce high-quality, real-time MRI images, which could enable oncologists to target radiation far more accurately while it is being applied.

Working towards a clinical prototype, the research team is hoping to start the first clinical tests in a year's time.


'/>"/>

Contact: Lena Weber
lena.weber@iop.org
44-207-470-4896
Institute of Physics
Source:Eurekalert

Page: 1

Related biology news :

1. New technique can be breakthrough for early cancer diagnosis
2. Breakthrough research identifies how cells from pigs may cure diabetes
3. Male contraception breakthroughs to be presented, Seattle Sept. 27-28
4. Major genetic breakthrough for ankylosing spondylitis brings treatment hope
5. Oosight microscope enables embryonic stem cell breakthrough
6. Brain-computer link systems on the brink of breakthrough, study finds
7. Breakthrough technology observes synapse in real time, supporting theory of vesicular recycling
8. Medical breakthrough for organ transplants and cardiovascular diseases by Flemish researchers
9. Genetic breakthrough offers promise in tackling kidney tumors
10. University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
11. Further breakthroughs for breast cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
(Date:12/2/2009)PHILADELPHIA Children exposed to secondhand cigarette smoke have an increased risk of developing lung cancer in adulthood, even if they never smoked. , Results of this study are published in Cance
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Cigarette smoking increases colorectal cancer risk 2PDI Reports 2009 Second Quarter Financial Results 13399 1PDI Reports 2009 Second Quarter Financial Results 13399 2PDI Reports 2009 Second Quarter Financial Results 13399 3PDI Reports 2009 Second Quarter Financial Results 13399 4PDI Reports 2009 Second Quarter Financial Results 13399 5PDI Reports 2009 Second Quarter Financial Results 13399 6PDI Reports 2009 Second Quarter Financial Results 13399 7PDI Reports 2009 Second Quarter Financial Results 13399 8PDI Reports 2009 Second Quarter Financial Results 13399 9Orexigen 28R 29 Therapeutics to Speak at Canaccord Adams Global Growth Conference 13397 1ADVENTRX to Hold Second Quarter Results and Business Update Conference Call on August 12 13395 1
...st of its kind study examining the effects of meth...g appears to cause abnormal brain development in c..., 2009, online issue of Neurology , the medical j..."Methamphetamine use is an increasing problem amon...ing number of children with prenatal meth exposure...
... 2009 Immigrant women are less likely to use foli...na bifida, particularly those who recently immigra...y a St. Michael,s Hospital physician in collaborat...University of Toronto. The study is the first to p...cid use in Canada. , "Our study,s findings report...
... Cincinnati (UC) cancer cell biologists have ident...cer susceptibility and development. They say this ...position to develop lung cancer for people with a ...ther investigation, they believe the gene could be...it from earlier, more aggressive lung cancer scree...
Other Biology News:Prenatal meth exposure linked to abnormal brain development 2Immigrant women may be at higher risk of having a baby with a birth defect 2Researchers identify specific lung cancer susceptibility gene 2
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5
...al Branding Strategy, ST. LOUIS, April 30 Sigma-...tegration of its Riedel-de Haen(R),Laboratory Reag... 2008,( http://www.sigma-aldrich.com/rebranding )....e with our products and,services," said Josef Zihl... for the Research Specialties and Research Essenti...
...s,Inc. (Nasdaq: CADX ), a biopharmaceutical compa...alizing proprietary product candidates principally...that the company,s,President and CEO Theodore Schr...w at the following investment conferences:, -- D...t the InterContinental Hotel in Boston on Tues...
...mpany (NYSE: BMY ) invites investors and the gene...eting with stockholders at 10 a.m. ET on Tuesday,M...rd items to be,transacted, senior executives will ... information on how to listen to the webcast, plea...l-Myers Squibb website at, http://www.bms.com/ir ....
Other Biology Technology:Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands 2Sigma-Aldrich Announces the Integration of Riedel-De Haen Into Core Product Brands 3Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May 2008 2
...icant secondary structure are often very difficult...ittle or no product. Yield, specificity and consis...g agents in PCR amplification reactions. Polymer-A...ates., Polymer-Aide is designed for molecular bi...
MutaGEL Parodontitis from Alpco Diagnostics
... Enhancer (with betaine) substantially improves PC...specificity for amplification of many DNA template...the base-pair composition dependence of DNA meltin...s pauses of DNA polymerase, and reduces secondary ...
...strip holder is designed for use with any Costar f...ew product number, created to easily match Corning...please order under the old Sigma-Aldrich number (Z...ce. ID clarifier: "egg crate" strip holder Sterili...
Biology Products: